Baker Bros. Advisors’s Mural Oncology MURA Stock Holding History

Baker Bros. Advisors’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-222,503	Closed	-$1.09M	–	99
2024 Q1	$1.09M	Buy	+222,503	New	+$1.08M	0.01%	78

Other funds holding MURA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baker Bros. Advisors's MURA Position: Q2 2024 in Review

Baker Bros. Advisors sold out of Mural Oncology (MURA) in Q2 2024, closing a stake of 222,503 shares — an estimated $1.09M sold.

Baker Bros. Advisors first reported a position in MURA in Q1 2024 and held it in 1 quarter. The position peaked at $1.09M in Q1 2024. 86 funds tracked by Wall St. Rank hold MURA as of Q2 2024.

Baker Bros. Advisors reported no remaining Mural Oncology position as of Q2 2024 after selling out during the quarter.
Baker Bros. Advisors sold 222,503 Mural Oncology shares in Q2 2024, an estimated $1.09M.
Baker Bros. Advisors first reported a position in Mural Oncology in Q1 2024 and held it in 1 quarter.
Baker Bros. Advisors's Mural Oncology position peaked at $1.09M in Q1 2024.
86 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2024.

Based on Baker Bros. Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.